Related Experiment Video

Updated: Jun 19, 2026

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and

Kyu Lim1, Chang Han, Yifan Dai

  • 1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. kyulim@cnu.ac.kr

Molecular Cancer Therapeutics
|November 6, 2009
PubMed

Insights

Omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), show promise for treating hepatocellular carcinoma (HCC). These omega-3 PUFAs inhibit HCC growth by targeting COX-2 and beta-catenin pathways.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer with high mortality and limited treatment options.
  • The cyclooxygenase-2 (COX-2) and Wnt/beta-catenin signaling pathways are implicated in liver cancer development.
  • Omega-3 polyunsaturated fatty acids (PUFAs) are being investigated for their potential anti-cancer effects.

Purpose of the Study:

  • To investigate the inhibitory effects of omega-3 PUFAs, specifically DHA and EPA, on HCC growth.
  • To elucidate the molecular mechanisms underlying the anti-cancer activity of DHA and EPA in HCC.
  • To evaluate the potential of omega-3 PUFAs for HCC chemoprevention and treatment.

Main Methods:

  • Treatment of human HCC cell lines (Hep3B, Huh-7, HepG2) with DHA and EPA.
  • Analysis of cell viability, apoptosis markers (PARP, caspase-3, caspase-9), and protein expression.
  • Investigation of signaling pathways including GSK-3beta, beta-catenin, and COX-2.
  • In vivo studies using Fat-1 transgenic mice and HCC xenografts.

Main Results:

  • DHA and EPA significantly reduced HCC cell viability in a dose-dependent manner, inducing apoptosis.
  • Omega-3 PUFAs led to the degradation of beta-catenin via GSK-3beta activation and the formation of a beta-catenin/Axin/GSK-3beta complex.
  • DHA inhibited PGE(2) signaling by downregulating COX-2 and upregulating 15-hydroxyprostaglandin dehydrogenase.
  • Omega-6 PUFA (AA) showed no significant effect on HCC cell viability.
  • Tumor growth was reduced in vivo in Fat-1 transgenic mice, which endogenously produce omega-3 PUFAs.

Conclusions:

  • Omega-3 PUFAs (DHA and EPA) effectively inhibit HCC cell growth and induce apoptosis through simultaneous inhibition of COX-2 and beta-catenin signaling.
  • These findings provide preclinical evidence supporting the use of omega-3 PUFAs for the chemoprevention and treatment of human HCC.
  • Targeting COX-2 and Wnt/beta-catenin pathways with omega-3 PUFAs represents a promising therapeutic strategy for HCC.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...